The TECR Gene Mental Retardation Autosomal Recessive Type 14 Genetic Test is a specialized diagnostic assessment conducted at DNA Labs UAE, designed to identify mutations in the TECR gene, which have been linked to a specific form of autosomal recessive intellectual disability (ID), known as Type 14. This condition is characterized by varying degrees of cognitive impairment, developmental delays, and in some cases, additional physical or neurological symptoms. The test is crucial for families seeking to understand the genetic underpinnings of intellectual disabilities and is instrumental in guiding treatment plans, interventions, and support services tailored to the individual's needs.
Conducted through a comprehensive analysis of the patient's DNA, the test looks for specific genetic alterations in the TECR gene that are responsible for the disorder. Early diagnosis through genetic testing can provide significant benefits, including access to targeted therapies, enrollment in special education programs, and the ability to connect with supportive communities and resources.
The cost of the TECR Gene Mental Retardation Autosomal Recessive Type 14 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expense of the sophisticated genetic analysis required to detect the presence of the TECR gene mutations. Families and individuals considering this test are advised to consult with genetic counselors and healthcare professionals to fully understand the implications of the results and to explore the most appropriate next steps in care and support.
The MAN1B1 gene is associated with a condition known as Mental Retardation, Autosomal Recessive Type 15 (MRT15). This rare genetic disorder is characterized by intellectual disabilities and, in some cases, physical abnormalities. The condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the altered gene, one from each parent, to be affected.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the MAN1B1 gene, which can confirm a diagnosis of MRT15. This test is crucial for families seeking answers about intellectual disabilities and for guiding potential treatment and management strategies. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and then analyzing the genetic material for specific mutations associated with the condition.
The cost of the MAN1B1 Gene Mental Retardation Autosomal Recessive Type 15 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of sample collection, genetic analysis, and a comprehensive report of the findings. The results of this test can provide essential information for affected individuals and their families, including the confirmation of a diagnosis, insights into the condition, and information relevant to family planning.
The CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CRBN gene. These mutations are associated with a rare form of intellectual disability, known as Autosomal Recessive Mental Retardation Type 2. This condition is characterized by significant cognitive, social, and developmental delays, and it is inherited in an autosomal recessive pattern, meaning that an affected individual receives a defective gene from each parent.
The test is conducted through a comprehensive analysis of the patient's DNA, specifically targeting the CRBN gene to detect any anomalies or mutations that may be responsible for the condition. This genetic test is crucial for early diagnosis and management of the disorder, allowing for tailored therapeutic interventions and support to improve the quality of life for affected individuals and their families.
The cost of the CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CRBN gene and provide reliable results. Early detection through this test can be a critical step in managing the condition effectively, offering insights into potential treatments and supportive measures.
The LINS1 Gene Mental Retardation Autosomal Recessive Type 27 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the LINS1 gene. These mutations are associated with a rare condition known as Mental Retardation, Autosomal Recessive Type 27, a disorder that affects intellectual development and may cause other physical and neurological issues. The test is crucial for early diagnosis, enabling appropriate interventions and support for affected individuals and their families. Conducted in a state-of-the-art facility, the test involves analyzing the patient's DNA sample to identify any genetic abnormalities in the LINS1 gene. Priced at 4400 AED, this genetic test is a valuable tool for healthcare professionals and families seeking to understand and manage the implications of this autosomal recessive condition.
The "CC2D1A Gene Mental Retardation Autosomal Recessive Type 3 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CC2D1A gene. This gene has been associated with a form of mental retardation known as Autosomal Recessive Type 3. Mental retardation, now more commonly referred to as intellectual disability, is characterized by below-average intellectual function and a lack of skills necessary for daily living. The condition linked to the CC2D1A gene affects cognitive development and can present various degrees of intellectual disability from mild to severe.
The test is particularly important for families with a history of this condition, offering them a chance to understand their genetic status and make informed decisions regarding family planning. It can also provide essential information for the management and support of individuals with the condition, allowing for tailored educational and developmental interventions.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the CC2D1A gene that are known to cause Autosomal Recessive Type 3 mental retardation.
The cost of the test is 4400 AED, which reflects the specialized nature of the genetic analysis and the profound impact the results can have on individuals and families. While the cost may be significant, the value of the information gained can be invaluable for affected families, providing a clear genetic diagnosis and guiding future decisions regarding health and family planning.
The ADAT3 Gene Mental Retardation Autosomal Recessive Type 36 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ADAT3 gene, which are linked to a rare form of autosomal recessive intellectual disability. This condition, known as Mental Retardation, Autosomal Recessive Type 36, is characterized by developmental delays, intellectual challenges, and possibly other neurological or physical symptoms. The test is crucial for families seeking a definitive diagnosis to understand the genetic underpinnings of intellectual disabilities within their family, potentially guiding treatment and support options.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing services, the test requires a DNA sample, typically obtained through a blood draw. The process involves analyzing the genetic material for specific mutations in the ADAT3 gene that are responsible for this condition. The outcome of this test not only aids in confirming a diagnosis but also helps in genetic counseling, where families can understand the risk of recurrence in future pregnancies.
The cost of the ADAT3 Gene Mental Retardation Autosomal Recessive Type 36 Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the genetic analysis, including the sophisticated technology and expertise required to accurately identify mutations in the ADAT3 gene. For families and individuals undergoing this test, the results can provide invaluable insights into their condition, offering a pathway towards more tailored and effective management strategies.
The ARID1B Gene Mental Retardation Autosomal Dominant Type 12 Genetic Test is a specialized diagnostic tool designed to identify mutations in the ARID1B gene, which are linked to a form of intellectual disability known as Autosomal Dominant Mental Retardation Type 12. This condition is characterized by developmental delays, intellectual challenges, and in some cases, physical abnormalities. The ARID1B gene plays a critical role in chromatin remodeling, which is essential for DNA repair, replication, and gene expression.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the ARID1B gene. This genetic test is crucial for families seeking a diagnosis for intellectual disability, as it can provide definitive answers and help guide treatment and management strategies.
Conducted at DNA Labs UAE, the test is available for a cost of 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals specialized in genetic testing, ensuring accurate and reliable results. The test is recommended for individuals with clinical symptoms of Autosomal Dominant Mental Retardation Type 12 or for families with a history of the condition, aiming to provide them with crucial information for managing the condition effectively.
The DYNC1H1 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene are associated with Mental Retardation Autosomal Dominant Type 13 (MRD13), a condition characterized by intellectual disabilities and, in some cases, neurological and muscular impairments. The genetic test for MRD13 focuses on identifying mutations in the DYNC1H1 gene to confirm a diagnosis, guide treatment options, and offer genetic counseling.
At DNA Labs UAE, individuals can undergo the DYNC1H1 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test. This test is meticulously designed to detect the specific genetic alterations within the DYNC1H1 gene that are linked to the condition. With a cost of 4400 AED, the test provides a valuable resource for families seeking answers about MRD13, enabling them to make informed decisions about their health and care. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for the presence of mutations in the DYNC1H1 gene. Results from this test can offer crucial insights into the condition, facilitating personalized treatment plans and supporting early intervention strategies.
The TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the TRAPPC9 gene, which have been associated with a specific form of intellectual disability known as Autosomal Dominant Mental Retardation Type 13. This condition is characterized by various degrees of cognitive impairment, developmental delays, and in some cases, additional neurological or physical anomalies. The test is crucial for families seeking a definitive diagnosis, understanding the genetic basis of the condition, and making informed decisions about care and management.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves collecting a DNA sample, typically through a blood draw or cheek swab, and examining the genetic material for specific mutations in the TRAPPC9 gene. The process employs advanced genetic sequencing technologies to ensure accurate and reliable results.
The cost of the TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test is set at 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to targeted interventions, supports, and potentially participating in research studies aimed at finding treatments or understanding the condition better. Families considering this test are encouraged to consult with genetic counselors or specialists in genetic medicine to discuss the implications of the test results and the best path forward.
The ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test is a specialized diagnostic tool designed to identify mutations in the ARID1A gene, which are linked to a form of mental retardation characterized as Autosomal Dominant Type 14. This condition is part of a broader spectrum of intellectual disabilities that can vary in severity and is inherited in an autosomal dominant manner, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, this test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to detect any mutations in the ARID1A gene that could be responsible for the condition.
The cost of the ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated equipment and expertise required to accurately identify gene mutations and interpret the results.
This test is crucial for families seeking answers about intellectual disabilities and offers insights that can guide decisions about care and support. It also has implications for genetic counseling, helping families understand the risk of passing the condition to future generations.
